SGL-TX-MR—study protocol acute effects of SGLT2 inhibitor on kidney allograft oxygen tension, a randomized, double-blind, placebo controlled crossover trial

Lotte Borg Lange, Claus Bistrup · 2025

Read SGL-TX-MR—study protocol acute effects of SGLT2 inhibitor on kidney allograft oxygen tension, a randomized, double-blind, placebo controlled crossover trial by Lotte Borg Lange, Claus Bistrup (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12751442.txt.

Description

Drugs called SGLT2 inhibitors help protect kidneys, but no one had tested their quick effect in people who got a donor kidney and do not have diabetes. Lotte Borg Lange and Claus Bistrup set out a 2025 trial plan to fill that gap. Their study will take place at a transplant clinic at Odense University Hospital.

Eight adults with a stable donor kidney will each take a single dose of the drug and a placebo pill, in random order, with two weeks between the rounds. Scans that track oxygen in the kidney are the main measure, with blood flow, blood sugar, and blood pressure also checked. The team wants to learn if one dose raises oxygen levels in the kidney within hours. The results could guide later, larger trials in transplant care.

Catalog record

CREATORLotte Borg Lange, Claus Bistrup
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE107 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12751442

Browse the full library · About the Tower of Babel